Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma

被引:121
|
作者
Lipson, Evan J. [1 ]
Bodell, Mabel A.
Kraus, Edward S.
Sharfman, William H.
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
关键词
SOLID-ORGAN TRANSPLANT; RECIPIENTS;
D O I
10.1200/JCO.2013.49.2314
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E69 / E71
页数:3
相关论文
共 50 条
  • [1] Successful Combination of Electrochemotherapy and Ipilimumab in Metastatic Melanoma
    Hauptmann, N.
    Schaefer, S.
    Hauschild, A.
    Kaehler, K. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 17 - 17
  • [2] Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma
    Stein, Matthew K.
    Summers, Bryant B.
    Wong, Christine A.
    Box, Hilary L.
    Cleveland, Kerry O.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (06): : 512 - 513
  • [3] Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
    Pedersen, Magnus
    Andersen, Rikke
    Norgaard, Peter
    Jacobsen, Soren
    Thielsen, Peter
    Straten, Per Thor
    Svane, Inge Marie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (12) : 1341 - 1346
  • [4] Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
    Magnus Pedersen
    Rikke Andersen
    Peter Nørgaard
    Søren Jacobsen
    Peter Thielsen
    Per thor Straten
    Inge Marie Svane
    Cancer Immunology, Immunotherapy, 2014, 63 : 1341 - 1346
  • [5] Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
    Jeter, Joanne M.
    Cranmer, Lee D.
    Hersh, Evan M.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [6] Administration of Ipilimumab to a Liver Transplant Recipient With Unresectable Metastatic Melanoma
    Ranganath, Harsha A.
    Panella, Timothy J.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (05) : 211 - 211
  • [7] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08): : 711 - 723
  • [8] Ipilimumab improves survival in metastatic melanoma patients
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    IMMUNOTHERAPY, 2011, 3 (08) : 928 - 929
  • [9] Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    Lawrence, Donald
    Lezcano, Cecilia
    Wu, Xinqi
    Zhou, Jun
    Sasada, Tetsuro
    Zeng, Wanyong
    Giobbie-Hurder, Anita
    Atkins, Michael B.
    Ibrahim, Nageatte
    Friedlander, Philip
    Flaherty, Keith T.
    Murphy, George F.
    Rodig, Scott
    Velazquez, Elsa F.
    Mihm, Martin C., Jr.
    Russell, Sara
    DiPiro, Pamela J.
    Yap, Jeffrey T.
    Ramaiya, Nikhil
    van den Abbeele, Annick D.
    Gargano, Maria
    McDermott, David
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 632 - 642
  • [10] IPILIMUMAB FOR METASTATIC MELANOMA
    Ozao-Choy, J.
    Carvajal, R. D.
    Hamid, O.
    DRUGS OF TODAY, 2012, 48 (06) : 381 - 393